Search
Search Results
##search.searchResults.foundPlural##
-
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3551PDF: 2411HTML: 1463 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1117PDF: 487HTML: 233 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7442PDF: 2421HTML: 1733Table 1.: 208Table 2.: 217Table 3.: 201Table 4.: 200 -
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
2116PDF: 820HTML: 1639Figure 1: 304 -
-
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2631PDF: 943HTML: 3605 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4088PDF: 1240HTML: 1955Table 1: 195 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1538PDF: 785HTML: 1476Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 179 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3315PDF: 1316HTML: 6191 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1257PDF: 527HTML: 23044 -
BONE MARROW ABONRMALITIES IN HIV INFECTION
1870PDF: 1134HTML: 1757 -
Common parasite with uncommon associations
1505PDF: 668HTML: 1835 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1380PDF: 1306HTML: 99 -
Osteolytic bone lesions – A rare presentation of AML M6.
1971PDF: 1095HTML: 7936Untitled: 203 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
942PDF: 513HTML: 193 -
“Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency. Hemolysis by Hemolysis and G6PD deficiency.
1269PDF: 979HTML: 337 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3545PDF: 1488HTML: 4395CoverLetter: 184Figure1: 194 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5147PDF: 1321HTML: 2744Cover letter: 193 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2491PDF: 922HTML: 530 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2100PDF: 991HTML: 4070Cover Letter: 221Figure 1: 233Figure 2: 230Table 1: 204 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1808PDF: 809HTML: 10234Figures 1,2,3: 173 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2780PDF: 1015HTML: 360Preferred Reviewers: 205 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1239PDF: 756HTML: 315 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3261PDF: 1091HTML: 437







